Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma

• Anne Lok,
• Julie Mocquard,
• Jessie Bourcier,
• Laurence Redelsperger,
• Antoine Bonnet,
• Cecile Chauvin,
• Patrick Thomaré,
• Beatrice Mahé,
• Cyrille Touzeau,
• Philippe Moreau

Affiliations

Anne Lok

Hematology Department, University Hospital, Nantes, France

Julie Mocquard

Hematology Department, University Hospital, Nantes, France

Jessie Bourcier

Hematology Department, University Hospital, Nantes, France

Laurence Redelsperger

Hematology Department, University Hospital, Nantes, France

Antoine Bonnet

Hematology Department, University Hospital, Nantes, France

Cecile Chauvin

Hematology Department, University Hospital, Nantes, France

Patrick Thomaré

Hematology Department, University Hospital, Nantes, France

Beatrice Mahé

Hematology Department, University Hospital, Nantes, France

Cyrille Touzeau

Hematology Department, University Hospital, Nantes, France

Philippe Moreau

Hematology Department, University Hospital, Nantes, France